BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 9612474)

  • 1. Population-based breast cancer screening: policy advice for a New Zealand screening programme. Breast Cancer Screening Policy Advisory Group.
    N Z Med J; 1998 Apr; 111(1064):138-42. PubMed ID: 9612474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The costs of mammography screening in New Zealand: evidence from the pilot programmes.
    Menon A; Devlin NJ; Richardson AK
    N Z Med J; 1994 Dec; 107(991):501-3. PubMed ID: 7830979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mammography screening for breast cancer in Copenhagen April 1991-March 1997. Mammography Screening Evaluation Group.
    Lynge E
    APMIS Suppl; 1998; 83():1-44. PubMed ID: 9850674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A survey of urban and rural participants in the Otago-Southland pilot breast cancer screening programme.
    Richardson AK; Elwood JM; McNoe B; Bang E
    N Z Med J; 1994 Feb; 107(971):36-8. PubMed ID: 8302502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mammographic screening for breast cancer: prospects for New Zealand.
    Skegg D; Paul C; Benson-Cooper D; Chetwynd J; Clarke A; Fitzgerald N; Gray A; St George I; Simpson A
    N Z Med J; 1988 Aug; 101(852):531-3. PubMed ID: 3045716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast cancer detection rates, and standardised detection ratios for prevalence screening in the New Zealand breast cancer screening programme.
    Richardson A; Graham P; Brown T; Smale P; Cox B
    J Med Screen; 2004; 11(2):65-9. PubMed ID: 15153320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospects for population colorectal cancer screening in New Zealand.
    Parry S; Richardson A; Green T; Marshall B; Bissett I; Bloomfield A; Chadwick V; Cunningham C; Findlay M; Greer B; McMenamin J; Strid J; Robertson G; Teague C
    N Z Med J; 2007 Jul; 120(1258):U2633. PubMed ID: 17653251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast cancer screening for women aged 40 to 49 years--what does the evidence mean for New Zealand?
    Baker S; Wall M; Bloomfield A
    N Z Med J; 2005 Aug; 118(1221):U1628. PubMed ID: 16138166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of service screening on breast cancer mortality rates.
    Cox B
    Eur J Cancer Prev; 2008 Aug; 17(4):306-11. PubMed ID: 18562953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recommendations on population screening for colorectal cancer in New Zealand. Members of the National Health Committee Working Party on Population Screening for Colorectal Cancer.
    N Z Med J; 1999 Jan; 112(1080):4-6. PubMed ID: 10073156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The 2003 Australian Breast Health Survey: survey design and preliminary results.
    Villanueva EV; Jones S; Nehill C; Favelle S; Steel D; Iverson D; Zorbas H
    BMC Public Health; 2008 Jan; 8():13. PubMed ID: 18194528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolution of breast cancer screening in countries with intermediate and increasing incidence of breast cancer.
    Wu GH; Chen LS; Chang KJ; Hou MF; Chen SC; Liu TJ; Huang CS; Hsu GC; Yu CC; Jeng LL; Chen ST; Chou YH; Wu CY; Shin-Lan K; Chen TH;
    J Med Screen; 2006; 13 Suppl 1():S23-7. PubMed ID: 17227638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for breast cancer in England: past and future.
    Advisory Committee on Breast Cancer Screening
    J Med Screen; 2006; 13(2):59-61. PubMed ID: 16792825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can Flemish women in semi-rural areas be motivated to attend organized breast cancer screening?
    Van Hal G; Matthyssen M; Thibaut A; Weyler J
    Rev Epidemiol Sante Publique; 1999 Apr; 47(2):119-27. PubMed ID: 10367299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [CBO guideline 'Breast cancer: screening and diagnosis'].
    Rutgers EJ; Tuut MK
    Ned Tijdschr Geneeskd; 2001 Jan; 145(3):115-9. PubMed ID: 11206120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The NCI All Ireland Cancer Conference.
    Johnston PG; Daly PA; Liu E
    Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Counting the costs of mammography screening: first year results from the Sydney study.
    Gerard K; Salkeld G; Hall J
    Med J Aust; 1990 May; 152(9):466, 469-71. PubMed ID: 2381337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of effectiveness of quality-assured mammography screening in Germany: sample size considerations and design options.
    Becker N; Hakama M; Nyström L
    Eur J Cancer Prev; 2007 Jun; 16(3):225-31. PubMed ID: 17415093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Contributions of the epidemiological cancer registries to the evaluation of mammography screening in Germany].
    Urbschat I; Kieschke J; Schlanstedt-Jahn U; von Gehlen S; Thiel A; Jensch P
    Gesundheitswesen; 2005 Jul; 67(7):448-54. PubMed ID: 16103967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Population screening for breast cancer: an interim assessment].
    van der Maas PJ
    Ned Tijdschr Geneeskd; 2000 Jun; 144(23):1096-9. PubMed ID: 10876703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.